Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system: A radiation oncology report of the Department of Defense Center for Prostate Disease Research

Peter A.S. Johnstone, Robert H. Riffenburgh, Judd W. Moul, Leon Sun, Hongyu Wu, David G. McLeod, Christopher J. Kane, Douglas D. Martin, Leo Kusuda, Raymond Lance, Robert Douglas, Timothy Donahue, Michael G. Beat, John Foley, Andrew Chung, Douglas Soderdahl, Jason Do, Christopher L. Amling

Research output: Contribution to journalArticle

23 Scopus citations

Abstract

Purpose: It has traditionally been a common perception that young age is a negative prognostic factor in prostate cancer (CaP). Furthermore, many urologists believe that younger patients are better suited to surgery rather than radiotherapy (RT) because of this perception. However, the data on the effect of age on outcome in patients with CaP are unclear. The records of the Department of Defense Center for Prostate Disease Research were queried for the biochemical disease-free results of patients after definitive RT and analyzed by age. Methods and Materials: The records of 1018 patients with T1-T3 CaP treated with definitive RT between 1988 and 2000 were reviewed. The records of patients receiving adjuvant hormonal therapy or adjuvant or salvage RT postoperatively were excluded. Biochemical failure was calculated by the American Society for Therapeutic Radiology and Oncology criteria. The median potential follow-up was 85.3 months as of December 31, 2001. Results: Age did not affect biochemical disease-free survival significantly when considered as <60 vs. ≥60 years (p = 0.646), by decade (p = 0.329), or as a continuous variable (correlation coefficient r = 0.017, regression slope = 0.007, with p = 0.588 and R2 < 0.001). Using multiple regression analysis, age was still not significant (p = 0.408). Other variables analyzed were pretreatment prostate-specific antigen level (p < 0.001), Gleason sum (p = 0.023), stage (p = 0.828), and RT dose (p = 0.033). Conclusion: Age and biochemical disease-free survival after RT for CaP are not related. Age may not be a valid factor in choosing between primary treatment options for CaP.

Original languageEnglish (US)
Pages (from-to)964-969
Number of pages6
JournalInternational Journal of Radiation Oncology Biology Physics
Volume55
Issue number4
DOIs
StatePublished - Mar 15 2003
Externally publishedYes

Keywords

  • Outcomes
  • Prostate neoplasms
  • Radiotherapy

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system: A radiation oncology report of the Department of Defense Center for Prostate Disease Research'. Together they form a unique fingerprint.

  • Cite this